{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:37:37Z","timestamp":1790080657838,"version":"4.0.1"},"reference-count":24,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2013.0356","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:25:18Z","timestamp":1525253118000},"source":"Crossref","is-referenced-by-count":6,"title":["One-Year Evaluation of a Neonatal Screening Program for Cystic Fibrosis in Switzerland"],"prefix":"10.3238","author":[{"given":"Corina S.","family":"Rueegg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia E.","family":"Kuehni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Gallati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Torresani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juerg","family":"Barben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2013,5,17]]},"reference":[{"key":"10.3238\/arztebl.2013.0356_ref1","doi-asserted-by":"crossref","unstructured":"Crossley JR, Elliot RB, Smith PA: Dried blood spot screening for cystic fibrosis in the newborn. Lancet 1979; 313: 472\u20134.","DOI":"10.1016\/S0140-6736(79)90825-0"},{"key":"10.3238\/arztebl.2013.0356_ref2","doi-asserted-by":"crossref","unstructured":"Crossley JR, Smith PA, Edgar BW, Gluckman PD, Elliott RB: Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots. Clin Chim Acta 1981; 113: 111\u201321.","DOI":"10.1016\/0009-8981(81)90145-5"},{"key":"10.3238\/arztebl.2013.0356_ref3","doi-asserted-by":"crossref","unstructured":"Massie J, Clements B: Diagnosis of cystic fibrosis after newborn screening: The Australasian experience\u2014twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group. Pediatr Pulmonol 2005; 39: 440\u20136.","DOI":"10.1002\/ppul.20191"},{"key":"10.3238\/arztebl.2013.0356_ref4","doi-asserted-by":"crossref","unstructured":"Balfour-Lynn IM: Newborn screening for cystic fibrosis: evidence for benefit. Arch Dis Child 2008; 93: 7\u201310.","DOI":"10.1136\/adc.2007.115832"},{"key":"10.3238\/arztebl.2013.0356_ref5","doi-asserted-by":"crossref","unstructured":"Brice P, Jarrett J, Mugford M: Genetic screening for cystic fibrosis: An overview of the science and the economics. J Cyst Fibros 2007; 6: 255\u201361.","DOI":"10.1016\/j.jcf.2007.02.002"},{"key":"10.3238\/arztebl.2013.0356_ref6","doi-asserted-by":"crossref","unstructured":"Southern KW, Munck A, Pollitt R, et al.: A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 2007; 6: 57\u201365.","DOI":"10.1016\/j.jcf.2006.05.008"},{"key":"10.3238\/arztebl.2013.0356_ref7","unstructured":"Grosse SD, Boyle CA, Botkin JR, et al.: Newborn Screening for Cystic Fibrosis: Evaluation of Benefit and Risks and Recommendations for State Newborn Screening Programs. MMWR 2004; 53(RR-13): 1\u201336."},{"key":"10.3238\/arztebl.2013.0356_ref8","doi-asserted-by":"crossref","unstructured":"Castellani C, Southern KW, Brownlee K, et al.: European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros 2009; 8: 153\u201373.","DOI":"10.1016\/j.jcf.2009.01.004"},{"key":"10.3238\/arztebl.2013.0356_ref9","doi-asserted-by":"crossref","unstructured":"Comeau AM, Accurso FJ, White TB, et al.: Guidelines for Implementation of Cystic Fibrosis Newborn Screening Programs: Cystic Fibrosis Foundation Workshop Report. Pediatrics 2007; 119: e495\u2013e518.","DOI":"10.1542\/peds.2006-1993"},{"key":"10.3238\/arztebl.2013.0356_ref10","doi-asserted-by":"crossref","unstructured":"Harms E, Olgem\u00f6ller B: Neonatal screening for metabolic and endocrine disorders. Dtsch Arztebl Int 2011; 108(1\u20132): 11\u201322.","DOI":"10.3238\/arztebl.2011.0011"},{"key":"10.3238\/arztebl.2013.0356_ref11","unstructured":"Barben J, Torresani T, Schoeni M, Gallati S, Baumgartner M: Neugeborenen-Screening auf Cystische Fibrose \u2013 ab 1. Januar auch in der Schweiz. Paediatrica 2010; 21: 38\u20139."},{"key":"10.3238\/arztebl.2013.0356_ref12","doi-asserted-by":"crossref","unstructured":"Barben J, Gallati S, Fingerhut R, Schoeni MH, Baumgartner MR, Torresani T: Retrospective analysis of stored dried blood spots from children with cystic fibrosis and matched controls to assess the performance of a proposed newborn screening protocol in Switzerland. J Cyst Fibros 2012; 11: 332\u20136.","DOI":"10.1016\/j.jcf.2012.01.001"},{"key":"10.3238\/arztebl.2013.0356_ref13","unstructured":"Barben J, Baumgartner M, Torresani T: Neugeborenen-Screening auf Cystische Fibrose. Forum News 2011; 3: 24\u20137."},{"key":"10.3238\/arztebl.2013.0356_ref14","doi-asserted-by":"crossref","unstructured":"Farrell PM, Rosenstein BJ, White TB, et al.: Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008; 153: 4\u201314.","DOI":"10.1016\/j.jpeds.2008.05.005"},{"key":"10.3238\/arztebl.2013.0356_ref15","doi-asserted-by":"crossref","unstructured":"LeGrys VA, Yankaskas JR, Quittell LM, Marshall BC, Mogayzel PJ, Jr: Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. J Pediatr 2007; 151: 85\u20139.","DOI":"10.1016\/j.jpeds.2007.03.002"},{"key":"10.3238\/arztebl.2013.0356_ref16","doi-asserted-by":"crossref","unstructured":"Barben J, Ammann RA, Metlagel A, Schoeni MH: Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis. J Pediatr 2005; 146: 183\u20138.","DOI":"10.1016\/j.jpeds.2004.08.085"},{"key":"10.3238\/arztebl.2013.0356_ref17","doi-asserted-by":"crossref","unstructured":"Desax MC, Ammann R, Hammer J, Schoeni M, Barben J: Nanoduct sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis. Eur J Pediatr 2008; 167: 299\u2013304.","DOI":"10.1007\/s00431-007-0485-0"},{"key":"10.3238\/arztebl.2013.0356_ref18","doi-asserted-by":"crossref","unstructured":"Green A, Kirk J: Guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis. Ann Clin Biochem 2007; 44: 25\u201334.","DOI":"10.1258\/000456307779596011"},{"key":"10.3238\/arztebl.2013.0356_ref19","doi-asserted-by":"crossref","unstructured":"Borowitz D, Parad RB, Sharp JK, et al.: Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr 2009; 155 (6, Supplement): 106\u201316.","DOI":"10.1016\/j.jpeds.2009.09.003"},{"key":"10.3238\/arztebl.2013.0356_ref20","doi-asserted-by":"crossref","unstructured":"Borowitz D, Robinson KA, Rosenfeld M, et al.: Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155(6, Supplement): 73\u201393.","DOI":"10.1016\/j.jpeds.2009.09.001"},{"key":"10.3238\/arztebl.2013.0356_ref21","doi-asserted-by":"crossref","unstructured":"Kerem E, Conway S, Elborn S, Heijerman H: Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005; 4: 7\u201326.","DOI":"10.1016\/j.jcf.2004.12.002"},{"key":"10.3238\/arztebl.2013.0356_ref22","unstructured":"International Society for Neonatal Screening (ISNS), Standing Committee on Quality Assurance: Lexicon of terms to be used in newborn screening. 2005; www.isns-neoscreening.org\/htm\/facts_sheets.htm. Last accessed April 2013."},{"key":"10.3238\/arztebl.2013.0356_ref23","doi-asserted-by":"crossref","unstructured":"Mayell SJ, Munck A, Craig JV, et al.: A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. J Cyst Fibros 2009; 8: 71\u20138.","DOI":"10.1016\/j.jcf.2008.09.005"},{"key":"10.3238\/arztebl.2013.0356_ref24","doi-asserted-by":"crossref","unstructured":"Beucher J, Leray E, Deneuville E, et al.: Psychological effects of false-positive results in cystic fibrosis newborn screening: a two-year follow-up. J Pediatr 2010; 156: 771\u20136.","DOI":"10.1016\/j.jpeds.2009.12.003"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:44:45Z","timestamp":1638798285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,17]]},"references-count":24,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2013.0356","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,17]]}}}